Sharon Kedar is a partner at Encodia and a board member at several companies, including Codex DNA, Hawthorne Effect, Inc., and 908 Devices. Sharon has also served on the board of Emulate, Inc. and IsoPlexis. Prior to their work in the private sector, Sharon was a venture capitalist with Northpond Ventures.
Sharon Kedar has an MBA from Harvard Business School and a BA in Economics from Rice University. Sharon is also a Chartered Financial Analyst (CFA) Charterholder.